Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 39 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Bella Donna Pharma from Scherpenheuvel-Zichem, company number BE0649552976, closed financial year 2025 with a result of € -35,953 after tax. For that financial year Bella Donna Pharma recorded a gross margin of € 103,339 and equity of € 16,693. Compared with financial year 2024, the result moved from € 333 to € -35,953. The company made a loss. The buffer shrank hard: equity is 68 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 6, 2026.
€ 16,693
▼ 68% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -35,953
▼ still € 333 profit in 2024
Profit after tax over the fiscal year.
€ 40,232
▼ 44% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -3,307.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 66,506
▼ 9% vs 2024
€ 66,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 275
▼ 60% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 424,394
▼ 12% vs 2024
€ 58,125 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 78,227
▲ 26% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 12,028
▲ 26% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 118,030 | € 153,659 | € 152,606 | € 103,339 | ▼ 32% |
| Profit after taxes | € -15,922 | € 9,237 | € 333 | € -35,953 | ▼ € 36,285 |
| Equity | € 43,076 | € 52,313 | € 52,645 | € 16,693 | ▼ 68% |
| Total debts | € 787,542 | € 756,067 | € 668,885 | € 638,615 | ▼ 5% |
| Cash | € 78,679 | € 89,727 | € 71,760 | € 40,232 | ▼ 44% |
| Land & buildings | € 431,351 | € 414,268 | € 397,184 | € 380,101 | ▼ 4% |
| Retained profit | € 23,076 | € 32,313 | € 32,645 | € -3,307 | ▼ € 35,953 |
| Bank debt | € 593,151 | € 537,805 | € 481,557 | € 424,394 | ▼ 12% |
| Balance sheet total | € 830,618 | € 808,380 | € 721,530 | € 655,308 | ▼ 9% |
| Employees (FTE) | - | 1 | 1 | 1 |
Key figures of Bella Donna Pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to Bella Donna Pharma?
What happened at Bella Donna Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 35,953 (▼ € 36,285 vs 2024). Source: NBB ↗
- New establishment in Scherpenheuvel-Zichem. KBO
- Start of the company according to the CBE. KBO
In short
From € 15,922 loss in 2022 to € 35,953 loss in 2025.
Paid € 968 in corporate taxes since 2022.
Best year ever: 2023, with € 9,237 profit.
On average € 103,300 of value added per employee in 2025.
Management
Behind Bella Donna Pharma are Julie De Loore and Dominique Desterke. Julie De Loore is also behind APOTHEEK DE LOORE, Millefeuille, Schaffen Pharma and STAMPER & MORTIER.
Directors
According to the 2025 annual accounts
Julie De Loore
Director
Also active at: APOTHEEK DE LOORE, Millefeuille, Schaffen Pharma, STAMPER & MORTIER
Dominique Desterke
Director
Establishments
Establishment units
Physical locations of this company
Ter Elzen 21
3271 Scherpenheuvel-Zichem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Details
- Company number
- 0649.552.976
- VAT number
- BE 0649.552.976
- Registered office
- Ter Elzen 21, 3271 Scherpenheuvel-Zichem
- Names & denominations
- Bella Donna Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 March 2016
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- apotheekkaggevinne.be
- Activities · NACE
Detailhandel in farmaceutische producten